0000950170-24-050769.txt : 20240430
0000950170-24-050769.hdr.sgml : 20240430
20240430183405
ACCESSION NUMBER: 0000950170-24-050769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240426
FILED AS OF DATE: 20240430
DATE AS OF CHANGE: 20240430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: List Alan
CENTRAL INDEX KEY: 0001858530
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 24899143
MAIL ADDRESS:
STREET 1: C/O PRECISION BIOSCIENCES, INC.
STREET 2: 302 EAST PETTIGREW STREET
CITY: DURHAM
STATE: NC
ZIP: 27701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
ownership.xml
4
X0508
4
2024-04-26
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001858530
List Alan
C/O PRECISION BIOSCIENCES, INC.
302 EAST PETTIGREW ST. SUITE A-100
DURHAM
NC
27701
false
true
false
false
Chief Medical Officer
false
Common Stock
2024-04-26
4
M
false
868
A
4034
D
Common Stock
2024-04-30
4
S
false
238
10.027
D
3796
D
Restricted Stock Units
2024-04-26
4
M
false
868
0
D
Common Stock
868
0
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2024.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.
The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $10.14. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/ Dario Scimeca, Attorney-in-Fact for Alan List
2024-04-30